Company Snapshot Home > Equity > Corporate Information > Company Snapshot
|
|
| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
375.50
|
|
Change (%)
|
-19.50 (-4.94%)
|
|
Best Buy (RS)
|
375.4(x129)
|
|
Best Sell (RS)
|
377.05(x61)
|
|
Today's Range (RS)
|
374.20
-
392.00
|
|
52-Week Range (RS)
|
256.40
-
401.20
|
|
Beta (1 Year)
|
0.74
|
|
|
|
|
|
| Index Details |
| BSE HC, BSE SmallCap |
| News |
|
Corporate Details |
| Fermenta Biotech receives FSSAI approval for its Vitamin D3 (Cholecalciferol) - Plant Source |
| Fermenta Biotech soars after FSSAI approves plant-based Vitamin D3 ingredient |
| Fermenta Biotech Ltd Surges 3.48% |
| Fermenta Biotech to convene AGM |
| Fermenta Biotech consolidated net profit declines 44.20% in the March 2026 quarter |
| Board of Fermenta Biotech recommends final dividend |
| Fermenta Biotech to hold board meeting |
| Fermenta Biotech consolidated net profit declines 65.65% in the December 2025 quarter |
| Fermenta Biotech to hold board meeting |
|
|
|
| Incoporation Year : 1951 |
| Chairman : Pradeep Manjunath Chandan |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs |
| Registered Office |
Fermenta Biotech Ltd
A-1501 DIL Complex Majiwada,
Ghodbunder Road Thane One,
Thane (West),
Maharashtra-400610 |
Phone:91-22-66230800/888
Fax:91-22-67980899 |
| E-Mail : srikant.sharma@dil.net; contact@dil.net |
| URL : http://www.fermentabiotech.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
29-Jun-2026 |
356.70 |
10.74 |
| 1Month |
08-Jun-2026 |
341.00 |
15.84 |
| 3Month |
06-Apr-2026 |
340.10 |
16.14 |
| 6Month |
06-Jan-2026 |
339.25 |
16.43 |
| 1Year |
07-Jul-2025 |
328.25 |
20.34 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| Motilal Oswal BSE Healthcare ETF |
0.02 |
0.01 |
| Bandhan BSE Healthcare Index Fund |
0.02 |
0.00 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Divis Laboratories Ltd |
6,773.90 |
-1.12 |
7,077.70 |
5,637.50 |
181,867.21 |
| Acutaas Chemicals Ltd |
3,381.70 |
-3.77 |
3,735.00 |
1,097.65 |
28,771.97 |
| Neuland Laboratories Ltd |
18,934.00 |
0.40 |
19,748.40 |
11,500.00 |
24,195.82 |
| Jubilant Pharmova Ltd |
983.25 |
-0.26 |
1,250.00 |
783.75 |
15,704.59 |
| Dishman Pharmaceuticals and Chemicals Ltd(Merged) |
301.05 |
0.00 |
0.00 |
0.00 |
4,858.77 |
|
|
|
|